Genetic Mutations and Immunological Features of Severe Combined Immunodeficiency Patients in Iran.
暂无分享,去创建一个
N. Rezaei | A. Aghamohammadi | M. Keramatipour | S. Shahkarami | M. Hamid | N. Parvaneh | H. Esmaeilzadeh | H. Abolhassani | R. Yazdani | S. Darougar | R. Mahdian | S. Shahbazi | S. Mahdaviani | H. Ahanchian | Tooba Momen | F. Behmanesh | M. Sadeghi-shabestari | S. Delavari | M. Shariat | Zahra Shahbazi | F. Kiaee | S. Aleyasin | Hassan Abolhassani
[1] M. Tavassoli,et al. National Consensus on Diagnosis and Management Guidelines for Primary Immunodeficiency , 2019 .
[2] Q. Pan-Hammarström,et al. Clinical implications of systematic phenotyping and exome sequencing in patients with primary antibody deficiency , 2018, Genetics in Medicine.
[3] M. Tavassoli,et al. Fourth Update on the Iranian National Registry of Primary Immunodeficiencies: Integration of Molecular Diagnosis , 2018, Journal of Clinical Immunology.
[4] Smita Y. Patel,et al. The United Kingdom Primary Immune Deficiency (UKPID) registry 2012 to 2017 , 2018, Clinical and experimental immunology.
[5] M. Barbouche,et al. New insights into physiopathology of immunodeficiency-associated vaccine-derived poliovirus infection; systematic review of over 5 decades of data. , 2018, Vaccine.
[6] Ken Kelley,et al. Sample-Size Planning for More Accurate Statistical Power: A Method Adjusting Sample Effect Sizes for Publication Bias and Uncertainty , 2017, Psychological science.
[7] M. Afarideh,et al. Clinical, immunologic, and genetic spectrum of 696 patients with combined immunodeficiency , 2017, The Journal of allergy and clinical immunology.
[8] Tong-Xin Chen,et al. Family History of Early Infant Death Correlates with Earlier Age at Diagnosis But Not Shorter Time to Diagnosis for Severe Combined Immunodeficiency , 2017, Front. Immunol..
[9] J. Verbsky,et al. Newborn Screening for Severe Combined Immunodeficiency-A History of the TREC Assay , 2017 .
[10] J. Franco,et al. Patients with Primary Immunodeficiencies Are a Reservoir of Poliovirus and a Risk to Polio Eradication , 2017, Front. Immunol..
[11] O. Sanal,et al. Investigation of Genetic Defects in Severe Combined Immunodeficiency Patients from Turkey by Targeted Sequencing , 2017, Scandinavian journal of immunology.
[12] N. Rezaei,et al. Vaccine-Derived Polioviruses and Children with Primary Immunodeficiency, Iran, 1995–2014 , 2016, Emerging infectious diseases.
[13] R. Sutter,et al. Update on Vaccine-Derived Polioviruses — Worldwide, January 2017–June 2018 , 2016, MMWR. Morbidity and mortality weekly report.
[14] Steven G F Wassilak,et al. Progress Toward Polio Eradication - Worldwide, 2015-2016. , 2016 .
[15] D. Kohn,et al. Gene Therapy for the Treatment of Primary Immune Deficiencies , 2016, Current Allergy and Asthma Reports.
[16] Jianguo Zhang,et al. Next Generation Sequencing Data Analysis in Primary Immunodeficiency Disorders – Future Directions , 2016, Journal of Clinical Immunology.
[17] L. Notarangelo,et al. Combined immunodeficiency in the United States and Kuwait: Comparison of patients' characteristics and molecular diagnosis. , 2015, Clinical immunology.
[18] A. Al-ghonaium,et al. Primary Immunodeficiency Diseases in Saudi Arabia: a Tertiary Care Hospital Experience over a Period of Three Years (2010–2013) , 2015, Journal of Clinical Immunology.
[19] R. Sutter,et al. Update on Vaccine-Derived Polioviruses — Worldwide, January 2014–March 2015 , 2015, MMWR. Morbidity and mortality weekly report.
[20] S. Spector,et al. Practice parameter for the diagnosis and management of primary immunodeficiency. , 2015, The Journal of allergy and clinical immunology.
[21] L. Notarangelo,et al. A hypomorphic recombination-activating gene 1 (RAG1) mutation resulting in a phenotype resembling common variable immunodeficiency. , 2014, The Journal of allergy and clinical immunology.
[22] M. Kanariou,et al. Primary Immunodeficiency Diseases: A 30-year Patient Registry from the Referral Center for Primary Immunodeficiencies in Greece , 2014, Journal of Clinical Immunology.
[23] R. Long,et al. Severe Combined Immunodeficiency (SCID) in Canadian Children: A National Surveillance Study , 2013, Journal of Clinical Immunology.
[24] J. Verbsky,et al. Screening for severe combined immunodeficiency in neonates , 2013, Clinical epidemiology.
[25] J. Casanova,et al. Primary immunodeficiencies: a rapidly evolving story. , 2013, The Journal of allergy and clinical immunology.
[26] I. Dalal,et al. The Application of Clinical Genetics the Genetic Basis of Severe Combined Immunodeficiency and Its Variants , 2022 .
[27] Sudhir Gupta,et al. Primary immunodeficiencies in India: a perspective , 2012, Annals of the New York Academy of Sciences.
[28] M. Houshmand,et al. IL7R and RAG1/2 genes mutations/polymorphisms in patients with SCID. , 2011, Iranian journal of allergy, asthma, and immunology.
[29] L. Notarangelo,et al. Severe Combined Immunodeficiency (SCID): from molecular basisto clinical management , 2011 .
[30] F. Cossu. Genetics of SCID , 2010, Italian journal of pediatrics.
[31] N. Rezaei,et al. Disseminated bacille Calmette-Guérin in Iranian children with severe combined immunodeficiency. , 2009, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[32] F. Alt,et al. Leaky severe combined immunodeficiency and aberrant DNA rearrangements due to a hypomorphic RAG1 mutation. , 2009, Blood.
[33] J. Puck. Population-based newborn screening for severe combined immunodeficiency: steps toward implementation. , 2007, The Journal of allergy and clinical immunology.
[34] N. Rezaei,et al. Frequency and Clinical Manifestations of Patients with Primary Immunodeficiency Disorders in Iran: Update from the Iranian Primary Immunodeficiency Registry , 2006, Journal of Clinical Immunology.
[35] E. Stiehm,et al. Potential costs and benefits of newborn screening for severe combined immunodeficiency. , 2005, The Journal of pediatrics.
[36] A. Fischer,et al. Severe combined immunodeficiency. A model disease for molecular immunology and therapy , 2005, Immunological reviews.
[37] A. Fischer. Severe combined immunodeficiencies (SCID) , 2000, Clinical and experimental immunology.
[38] A. Villa,et al. Molecular modeling of the Jak3 kinase domains and structural basis for severe combined immunodeficiency. , 2000, Clinical immunology.
[39] J. Puck,et al. Mutation analysis of IL2RG in human X-linked severe combined immunodeficiency. , 1997, Blood.
[40] Rosen Fs. Severe combined immunodeficiency: a pediatric emergency. , 1997, The Journal of pediatrics.
[41] M. Eslamian,et al. Clinical, Laboratory, and Molecular Findings for 63 Patients With Severe Combined Immunodeficiency: A Decade´s Experience. , 2017, Journal of investigational allergology & clinical immunology.
[42] F. Rosen. Severe combined immunodeficiency: a pediatric emergency. , 1997, The Journal of pediatrics.